We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Add your Insight

Manuscript deadline
15 July 2021

Cover image - Expert Review of Hematology

Expert Review of Hematology

Special Issue Editor(s)

Commissioning Editor: Mithi Ahmed , [email protected]

Guest Editor/Co-Editor-in-Chief: Professor Simon Harrison, Director of the Centre of Excellence in Cellular Immunotherapy at the Peter MacCallum Cancer Centre, Melbourne, Australia
[email protected]

Visit JournalArticles

Multiple Myeloma

Expert Review of Hematology is currently welcoming submissions for its upcoming Special Issue on Multiple Myeloma to be published in late 2021. Our new Co-Editor-In-Chief, Professor Simon Harrison will be guest editor. Though a cure for multiple myeloma has not yet been developed, pioneering research and drug development on this disease has led to huge advances in patient outlook and survival.

With multiple myeloma research dominating the hematology field, this special issue, will share expert insights on new developments in a number of areas ranging from novel immunotherapies and targeted therapies to our ever-growing understanding of its mechanisms and pathology, which are guiding new treatment approaches.

As well as expert insights, the issue also welcomes high-quality original research focusing on new developments. Publishing your work as part of this special issue is beneficial, as articles often receive more views and higher citation numbers.

Looking to Publish your Research?

We aim to make publishing with Taylor & Francis a rewarding experience for all our authors. Please visit our Author Services website for more information and guidance, and do contact us if there is anything we can help with!

Submission Instructions

  • Please select special issue when submitting your paper to Scholar One as well as a cover letter for consideration
  • The special issue welcomes Reviews, Original Research, Editorials, Drug Profiles, Systematic Reviews, Meta-analyses and Perspectives
  • This issue is currently scheduled for publication in late 2021

The deadline for articles submitted to be included in the Special Issue are as follows:

  • Rapid track: 1st August 2021
  • Fast track 15th August 2021

Please contact the commissioning editor for more information on our rapid and fast track services.

Taylor & Francis is committed to enabling sustainable open research initiatives that lead to more open scholarly communications. If you are interested in making your article for this special issue Open Access, you can learn more about our Open Access publishing options here: https://authorservices.taylorandfrancis.com/publishing-open-access/.

Instructions for AuthorsSubmit an Article